US Drops Vaccination Recommendations Amid Global Outcry Over Health Expert Warning
The US has become the only developed nation lagging behind its peers in vaccination rates, following the Trump administration's decision to scale back vaccination recommendations. The move, which effectively allows parents and doctors to decide when to administer certain vaccines, marks a significant shift away from the well-established vaccine schedule previously followed by the country.
Critics argue that this change has been driven more by ideology than scientific evidence, with experts warning of severe consequences for public health. Daniel Jernigan, former director of the National Center for Emerging Zoonotic Infectious Diseases, described the decision as an "astounding" escalation against vaccines. He stated that US health officials are "wanting fewer vaccines," and that they are inflating risks while downplaying benefits.
The changes have seen several key vaccine recommendations reduced or changed, including those for influenza, rotavirus, hepatitis A, RSV (respiratory syncytial virus), and meningococcal disease. The dengue vaccine will only be recommended in high-risk areas. In contrast, most other developed nations offer vaccines to all children under a universal childhood schedule.
Health officials have claimed that this new US approach is closer to those of peer countries, but the reality is that many of these nations follow similar schedules and recommend broader vaccination programs. Experts warn that the lack of access to healthcare in the US will exacerbate the issue of vaccine disparities.
US health authorities admit that some vaccines may only be recommended for "high-risk" populations, which can result in unequal access for certain groups of children, such as newborns with hepatitis B who are at a higher risk of getting sick. Critics argue that this approach is not justifiable based on scientific evidence and ignores decades of accumulated knowledge about vaccine safety and effectiveness.
Critics have accused the administration of bypassing established scientific procedures to make this decision, without public input or consultation with experts. This has led to concerns that the process for making transparent decisions on vaccines has been swept aside.
"This is very concerning," said Jake Scott, an infectious diseases specialist and clinical associate professor at Stanford University School of Medicine. "We need to follow what our peer countries are doing and have universal healthcare."
The move is seen as a worrying trend in public health policy, with many experts fearing that it sets a precedent for future changes driven by ideological rather than evidence-based considerations.
In the words of Daniel Jernigan, "the science hasn't changed. The only thing that's changed is who's making the decisions and what conclusions they want to reach."
The US has become the only developed nation lagging behind its peers in vaccination rates, following the Trump administration's decision to scale back vaccination recommendations. The move, which effectively allows parents and doctors to decide when to administer certain vaccines, marks a significant shift away from the well-established vaccine schedule previously followed by the country.
Critics argue that this change has been driven more by ideology than scientific evidence, with experts warning of severe consequences for public health. Daniel Jernigan, former director of the National Center for Emerging Zoonotic Infectious Diseases, described the decision as an "astounding" escalation against vaccines. He stated that US health officials are "wanting fewer vaccines," and that they are inflating risks while downplaying benefits.
The changes have seen several key vaccine recommendations reduced or changed, including those for influenza, rotavirus, hepatitis A, RSV (respiratory syncytial virus), and meningococcal disease. The dengue vaccine will only be recommended in high-risk areas. In contrast, most other developed nations offer vaccines to all children under a universal childhood schedule.
Health officials have claimed that this new US approach is closer to those of peer countries, but the reality is that many of these nations follow similar schedules and recommend broader vaccination programs. Experts warn that the lack of access to healthcare in the US will exacerbate the issue of vaccine disparities.
US health authorities admit that some vaccines may only be recommended for "high-risk" populations, which can result in unequal access for certain groups of children, such as newborns with hepatitis B who are at a higher risk of getting sick. Critics argue that this approach is not justifiable based on scientific evidence and ignores decades of accumulated knowledge about vaccine safety and effectiveness.
Critics have accused the administration of bypassing established scientific procedures to make this decision, without public input or consultation with experts. This has led to concerns that the process for making transparent decisions on vaccines has been swept aside.
"This is very concerning," said Jake Scott, an infectious diseases specialist and clinical associate professor at Stanford University School of Medicine. "We need to follow what our peer countries are doing and have universal healthcare."
The move is seen as a worrying trend in public health policy, with many experts fearing that it sets a precedent for future changes driven by ideological rather than evidence-based considerations.
In the words of Daniel Jernigan, "the science hasn't changed. The only thing that's changed is who's making the decisions and what conclusions they want to reach."